Selectis Health, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 0.158927 million compared to USD 0.158875 million a year ago. Revenue was USD 9.05 million compared to USD 9.58 million a year ago. Net loss was USD 2.26 million compared to USD 0.990925 million a year ago. Basic loss per share from continuing operations was USD 0.74 compared to USD 0.33 a year ago. Diluted loss per share from continuing operations was USD 0.74 compared to USD 0.33 a year ago.
For the nine months, sales was USD 0.475643 million compared to USD 0.469938 million a year ago. Revenue was USD 27.58 million compared to USD 29.8 million a year ago. Net loss was USD 0.337924 million compared to USD 0.203623 million a year ago. Basic loss per share from continuing operations was USD 0.12 compared to USD 0.07 a year ago. Diluted loss per share from continuing operations was USD 0.12 compared to USD 0.07 a year ago.